Intelligent Medicine Acquisition Corp Unit

Company Profile

Intelligent Medicine Acquisition Corp Unit had its IPO on 2021-11-05 under the ticker symbol IQMDU.

The company operates in the Financial Services sector and Shell Companies industry. Intelligent Medicine Acquisition Corp Unit has a staff strength of 0 employees.

Stock update

Shares of Intelligent Medicine Acquisition Corp Unit opened at $10.98 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $10.98 - $10.98, and closed at $10.98.

This is a 0% increase from the previous day's closing price.

A total volume of 0 shares were traded at the close of the day’s session.

In the last one week, shares of Intelligent Medicine Acquisition Corp Unit have increased by 0%.

Intelligent Medicine Acquisition Corp Unit's Key Ratios

Intelligent Medicine Acquisition Corp Unit has a market cap of $258.50 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.

In the last 12-months Intelligent Medicine Acquisition Corp Unit’s revenue was $0 with a gross profit of $0 and an EBITDA of $0. The EBITDA ratio measures Intelligent Medicine Acquisition Corp Unit's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Intelligent Medicine Acquisition Corp Unit’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, Intelligent Medicine Acquisition Corp Unit’s quarterly earnings growth was a negative -84.5% while revenue growth was a positive 0%.

Intelligent Medicine Acquisition Corp Unit’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Intelligent Medicine Acquisition Corp Unit’s profitability.

Intelligent Medicine Acquisition Corp Unit stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.

Intelligent Medicine Acquisition Corp Unit stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$214.03 million

Total Liabilities

$1.08 million

Operating Cash Flow

$341146.00

Capital Expenditure

$0

Dividend Payout Ratio

0%

Intelligent Medicine Acquisition Corp Unit ended 2024 with $214.03 million in total assets and $0 in total liabilities. Its intangible assets were valued at $214.03 million while shareholder equity stood at $202.40 million.

Intelligent Medicine Acquisition Corp Unit ended 2024 with $0 in deferred long-term liabilities, $1.08 million in other current liabilities, 213256510.00 in common stock, $-10857177.00 in retained earnings and $0 in goodwill. Its cash balance stood at $50152.00 and cash and short-term investments were $50152.00. The company’s total short-term debt was $0 while long-term debt stood at $0.

Intelligent Medicine Acquisition Corp Unit’s total current assets stands at $187580.00 while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $472999.00 and inventory worth $0.

In 2024, Intelligent Medicine Acquisition Corp Unit's operating cash flow was $341146.00 while its capital expenditure stood at $0.

Comparatively, Intelligent Medicine Acquisition Corp Unit paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$10.98

52-Week High

$11

52-Week Low

$9.9

Analyst Target Price

$

Intelligent Medicine Acquisition Corp Unit stock is currently trading at $10.98 per share. It touched a 52-week high of $11 and a 52-week low of $11. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $10.44 and 200-day moving average was $10.23 The short ratio stood at 0.52 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 165.7% are held by institutions.